Publication Information

{'id': 'https://openalex.org/W2320389026', 'doi': 'https://doi.org/10.1158/1538-7445.am2013-1871', 'title': 'Abstract 1871: Targeting nicotinamide phosphoribosyltransferase (NAMPT) in cancer therapy.', 'display_name': 'Abstract 1871: Targeting nicotinamide phosphoribosyltransferase (NAMPT) in cancer therapy.', 'publication_year': 2013, 'publication_date': '2013-04-01', 'ids': {'openalex': 'https://openalex.org/W2320389026', 'doi': 'https://doi.org/10.1158/1538-7445.am2013-1871', 'mag': '2320389026'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2013-1871', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5075353845', 'display_name': 'Cristina Travelli', 'orcid': 'https://orcid.org/0000-0002-9721-9572'}, 'institutions': [], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Cristina Travelli', 'raw_affiliation_strings': ['1Dipartimento di scienze dl farmaco, Novara, Italy;'], 'affiliations': [{'raw_affiliation_string': '1Dipartimento di scienze dl farmaco, Novara, Italy;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077534240', 'display_name': 'Sara Morlacchi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210152645', 'display_name': 'Fondazione Humanitas per la Ricerca', 'ror': 'https://ror.org/05fa04208', 'country_code': 'IT', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210152645']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Sara Morlacchi', 'raw_affiliation_strings': ['2Istituto Clinico Humanitas, Rozzano (Milano), Italy;'], 'affiliations': [{'raw_affiliation_string': '2Istituto Clinico Humanitas, Rozzano (Milano), Italy;', 'institution_ids': ['https://openalex.org/I4210152645']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022198325', 'display_name': 'Antonio Caldarelli', 'orcid': None}, 'institutions': [], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Antonio Caldarelli', 'raw_affiliation_strings': ['1Dipartimento di scienze dl farmaco, Novara, Italy;'], 'affiliations': [{'raw_affiliation_string': '1Dipartimento di scienze dl farmaco, Novara, Italy;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021119674', 'display_name': 'Antonio Sica', 'orcid': 'https://orcid.org/0000-0002-8342-7442'}, 'institutions': [{'id': 'https://openalex.org/I4210152645', 'display_name': 'Fondazione Humanitas per la Ricerca', 'ror': 'https://ror.org/05fa04208', 'country_code': 'IT', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210152645']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Antonio Sica', 'raw_affiliation_strings': ['3Dipartimento di scienze dl farmaco, Istituto clinico humanitas, Novara/milano, Italy.'], 'affiliations': [{'raw_affiliation_string': '3Dipartimento di scienze dl farmaco, Istituto clinico humanitas, Novara/milano, Italy.', 'institution_ids': ['https://openalex.org/I4210152645']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5024096995', 'display_name': 'Armando A. Genazzani', 'orcid': 'https://orcid.org/0000-0003-1923-7430'}, 'institutions': [], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Armando A. Genazzani', 'raw_affiliation_strings': ['1Dipartimento di scienze dl farmaco, Novara, Italy;'], 'affiliations': [{'raw_affiliation_string': '1Dipartimento di scienze dl farmaco, Novara, Italy;', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '73', 'issue': '8_Supplement', 'first_page': '1871', 'last_page': '1871'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11051', 'display_name': 'Sirtuins and Resveratrol in Medicine', 'score': 0.9792, 'subfield': {'id': 'https://openalex.org/subfields/2717', 'display_name': 'Geriatrics and Gerontology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11051', 'display_name': 'Sirtuins and Resveratrol in Medicine', 'score': 0.9792, 'subfield': {'id': 'https://openalex.org/subfields/2717', 'display_name': 'Geriatrics and Gerontology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10631', 'display_name': 'Cancer, Hypoxia, and Metabolism', 'score': 0.931, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9278, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/nicotinamide-phosphoribosyltransferase', 'display_name': 'Nicotinamide phosphoribosyltransferase', 'score': 0.97993755}, {'id': 'https://openalex.org/keywords/nicotinamide-mononucleotide', 'display_name': 'Nicotinamide mononucleotide', 'score': 0.86621666}, {'id': 'https://openalex.org/keywords/niacinamide', 'display_name': 'Niacinamide', 'score': 0.43643135}], 'concepts': [{'id': 'https://openalex.org/C2780391879', 'wikidata': 'https://www.wikidata.org/wiki/Q18035058', 'display_name': 'Nicotinamide phosphoribosyltransferase', 'level': 4, 'score': 0.97993755}, {'id': 'https://openalex.org/C75520062', 'wikidata': 'https://www.wikidata.org/wiki/Q15321392', 'display_name': 'NAD+ kinase', 'level': 3, 'score': 0.96744764}, {'id': 'https://openalex.org/C2777088662', 'wikidata': 'https://www.wikidata.org/wiki/Q21547155', 'display_name': 'Nicotinamide mononucleotide', 'level': 5, 'score': 0.86621666}, {'id': 'https://openalex.org/C2776901170', 'wikidata': 'https://www.wikidata.org/wiki/Q12499775', 'display_name': 'Nicotinamide adenine dinucleotide', 'level': 4, 'score': 0.781306}, {'id': 'https://openalex.org/C197957613', 'wikidata': 'https://www.wikidata.org/wiki/Q407280', 'display_name': 'Cofactor', 'level': 3, 'score': 0.50878793}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.50721884}, {'id': 'https://openalex.org/C2779728014', 'wikidata': 'https://www.wikidata.org/wiki/Q192423', 'display_name': 'Nicotinamide', 'level': 3, 'score': 0.5064472}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.4789296}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.46398664}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.46033818}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.4461332}, {'id': 'https://openalex.org/C2909408332', 'wikidata': 'https://www.wikidata.org/wiki/Q192423', 'display_name': 'Niacinamide', 'level': 4, 'score': 0.43643135}, {'id': 'https://openalex.org/C96232424', 'wikidata': 'https://www.wikidata.org/wiki/Q4118072', 'display_name': 'Cancer cell', 'level': 3, 'score': 0.41751498}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.35273552}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.06197974}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2013-1871', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.54, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2930335628', 'https://openalex.org/W2886034769', 'https://openalex.org/W2804522937', 'https://openalex.org/W2618669287', 'https://openalex.org/W2320389026', 'https://openalex.org/W2141537555', 'https://openalex.org/W2049388554', 'https://openalex.org/W2010278197', 'https://openalex.org/W2006740871', 'https://openalex.org/W2005629883'], 'abstract_inverted_index': {'Abstract': [0], 'Nicotinamide': [1], 'adenine': [2], 'dinucleotide': [3], '(NAD)': [4], 'metabolism': [5], 'has': [6, 20, 138, 188], 'been': [7, 122, 139, 157, 189], 'emerged': [8], 'as': [9, 192, 341], 'a': [10, 46, 60, 88, 125, 193, 263, 332, 342, 358, 392, 407], 'new': [11, 16], 'target': [12], 'pathway': [13], 'in': [14, 24, 28, 72, 142, 162, 169, 235, 246, 259, 305, 331, 344, 352, 375, 413, 438], 'developing': [15], 'cancer': [17, 130, 221, 240, 439], 'therapies.': [18], 'NAD': [19, 44, 65, 70, 112], 'principal': [21], 'two': [22, 149, 236], 'functions': [23], 'cells:': [25], '(i)': [26, 229], 'cofactor': [27], 'redox': [29, 47], 'reactions': [30], 'and': [31, 117, 129, 154, 159, 165, 174, 201, 213, 242, 249, 269, 354, 373], '(ii)': [32, 250], 'substrate': [33], 'of': [34, 37, 62, 119, 127, 145, 167, 172, 180, 204, 211, 217, 232, 239, 253, 256, 282, 361, 371, 387, 395, 444, 449], 'several': [35, 143, 202], 'classes': [36], 'NAD-dependent': [38, 101], 'enzymes': [39, 56], '(i.e.': [40], 'PARPs,': [41], 'sirtuins).': [42], 'When': [43], 'is': [45, 93, 108, 131, 357], 'carrier,': [48], 'its': [49], 'not': [50, 132, 311, 475], 'consumed': [51], 'by': [52, 100, 113, 199, 220], 'cells,': [53, 73, 277, 290], 'however': [54], 'NAD-utilizing': [55], 'degrade': [57], 'NAD,': [58], 'inducing': [59], 'decrease': [61], 'the': [63, 74, 178, 181, 209, 214, 230, 251, 368, 385, 445, 450, 478, 484], 'intracellular': [64], 'pool.': [66], 'Therefore,': [67, 299], 'to': [68, 95, 111, 271, 286, 296, 328, 366, 416, 488], 're-establish': [69], 'levels': [71, 281], 'so': [75], 'called': [76, 196], '“NAD': [77], 'salvage': [78], 'pathway”': [79], 'exists.': [80], 'In': [81, 274], 'this': [82, 91, 218], 'pathway,': [83], 'nicotinamide': [84, 97, 104, 435], 'phosphoribosyltransferase': [85, 436], '(NAMPT)': [86, 437], 'plays': [87], 'crucial': [89], 'role;': [90], 'enzyme': [92], 'able': [94, 327], 'convert': [96], '(Nam),': [98], 'released': [99, 198], 'enzymes,': [102], 'into': [103], 'mononucleotide': [105], '(NMN),': [106], 'which': [107, 278, 291], 'finally': [109], 'converted': [110], 'NMNAT.': [114], 'Different': [115], 'expression': [116, 248, 268], 'activity': [118, 315, 386], 'NAMPT': [120, 137, 151, 187, 233, 247, 257, 267, 272, 293, 308, 330, 337, 372, 383, 415], 'have': [121, 156, 227, 310, 318], 'correlated': [123], 'with': [124, 418], 'number': [126], 'pathologies,': [128], 'an': [133, 313], 'exception.': [134], 'For': [135], 'example,': [136], 'found': [140, 262, 322], 'up-regulated': [141], 'types': [144, 171, 203, 238], 'cancer.': [146], 'To': [147], 'date,': [148], 'potent': [150], 'inhibitors': [152, 234], '(FK866': [153], 'CHS828)': [155], 'discovered': [158], 'are': [160, 183, 223, 284, 294, 326, 350], 'now': [161], 'phase': [163], 'I': [164], 'II': [166], 'trials': [168, 182], 'different': [170, 237], 'solid': [173], 'non-solid': [175], 'cancers.': [176], 'However,': [177], 'results': [179, 380, 404], 'still': [184, 224], 'unpublished.': [185], 'Moreover,': [186], 'also': [190, 195, 340], 'described': [191], 'cytokine,': [194], 'visfatin,': [197], 'adipocytes': [200], 'activated': [205], 'immune': [206], 'cells.': [207], 'However': [208], 'function': [210], 'visfatin': [212, 374], 'possible': [215, 369], 'release': [216, 329], 'cytokine': [219, 343], 'cells': [222, 307, 325, 390], 'unknown.': [225], 'We': [226, 261, 321], 'investigated': [228], 'action': [231], '(neuroblastoma': [241], 'melanoma)': [243], 'that': [244, 304, 323, 336, 355, 382, 399], 'differ': [245], 'contribution': [252], 'extracellular': [254], 'form': [255], '(visfatin)': [258], 'tumour.': [260], 'positive': [264], 'correlation': [265], 'between': [266], 'responsiveness': [270], 'inhibitors.': [273], 'particular': [275], 'neuroblastoma': [276], 'express': [279], 'normal': [280], 'NAMPT,': [283], 'sensitive': [285], 'FK866,': [287], 'contrary': [288], 'melanoma': [289, 306, 345], 'over-expressed': [292], 'refractory': [295], 'FK866': [297], 'treatment.': [298], 'these': [300, 324], 'data': [301], 'may': [302, 309, 317], 'suggest': [303], 'only': [312], 'enzymatic': [314], 'but': [316], 'another': [319], 'function.': [320], 'time-dependent': [333], 'manner,': [334], 'suggesting': [335], 'could': [338, 405], 'act': [339], 'cell': [346], 'culture.': [347], 'Since': [348], 'cytokines': [349], 'involved': [351], 'inflammation,': [353], 'inflammation': [356], 'critical': [359], 'component': [360], 'tumour': [362, 401], 'progression,': [363], 'we': [364], 'decided': [365], 'investigate': [367], 'role': [370], 'tumour-related': [376, 419], 'inflammation.': [377, 420], 'Our': [378, 403], 'preliminary': [379], 'show': [381], 'altered': [384], 'myeloid-derived': [388], 'suppressor': [389], '(MDSC),': [391], 'heterogeneous': [393], 'population': [394], 'early': [396], 'myeloid': [397], 'progenitors': [398], 'facilitate': [400], 'progression.': [402], 'be': [406], 'starting': [408], 'point': [409], 'for': [410, 453], 'future': [411], 'direction': [412], 'targeting': [414], 'interfere': [417], 'Citation': [421], 'Format:': [422], 'Cristina': [423], 'Travelli,': [424], 'Sara': [425], 'Morlacchi,': [426], 'Antonio': [427, 429], 'Caldarelli,': [428], 'Sica,': [430], 'Armando': [431], 'A.': [432], 'Genazzani.': [433], 'Targeting': [434], 'therapy.': [440], '[abstract].': [441], 'In:': [442], 'Proceedings': [443], '104th': [446], 'Annual': [447, 480], 'Meeting': [448, 481], 'American': [451], 'Association': [452], 'Cancer': [454, 464], 'Research;': [455], '2013': [456, 482], 'Apr': [457], '6-10;': [458], 'Washington,': [459], 'DC.': [460], 'Philadelphia': [461], '(PA):': [462], 'AACR;': [463], 'Res': [465], '2013;73(8': [466], 'Suppl):Abstract': [467], 'nr': [468], '1871.': [469], 'doi:10.1158/1538-7445.AM2013-1871': [470], 'Note:': [471], 'This': [472], 'abstract': [473], 'was': [474, 486], 'presented': [476], 'at': [477], 'AACR': [479], 'because': [483], 'presenter': [485], 'unable': [487], 'attend.': [489]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2320389026', 'counts_by_year': [], 'updated_date': '2024-12-08T12:33:55.767966', 'created_date': '2016-06-24'}